Home
Conditions
Hemic and Lymphatic Diseases

Clinical trial condition

Hemic and Lymphatic Diseases

Explore clinical trials studying Hemic and Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

21,120 public trials 3,997 recruiting studies

Refine in advanced search Browse all conditions

Hemic and Lymphatic Diseases trial results

Recruiting

Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients

NCT04836507

Conditions: ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
Locations: Samsung Medical Center Seoul, South Korea

The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea

View Trial Details

Recruiting

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome

NCT04256018

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Stanford Cancer Center Stanford, California, United States

View Trial Details

Recruiting

Optimizing Health Related Quality of Life Measurement in Adolescent and Young Adult Oncology

NCT06897137

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic Neoplasms, +5 more
Locations: Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Recruiting

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

NCT03932903

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Recruiting

Iadademstat in Combination With Azacitidine and Venetoclax in Treating Newly Diagnosed Acute Myeloid Leukemia

NCT06357182

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Improving Comprehensive Care of Cancer Patients

NCT05323409

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Baylor College of Medicine Houston, Texas, United States

View Trial Details

Recruiting

A Study Assessing HMB-002 in Participants With Von Willebrand Disease

NCT06754852

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +12 more
Locations: Phoenix Children's Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Children's Hospital of Los Angeles Los Angeles, California, United States

University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center Miami, Florida, United States

View all 25 locations

View Trial Details

Recruiting

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

NCT06722586

Conditions: Antiphospholipid (aPL)-Positive, Blood Platelet Disorders, Cytopenia, +4 more
Locations: Xiangya Hospital of Central South University Changsha, Hunan, China

Qilu Hospital of Shandong University Jinan, Shangdong, China

West China Hospital, Sichuan University Chengdu, Sichuan, China

People's Hospital of Xinjiang Uygur Autonomous Region Ürümqi, Xinjiang, China

View Trial Details

Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Sobi Investigational Site Zagreb, Croatia

Sobi Investigational Site Brno, Czechia

Sobi Investigational Site Ostrava, Czechia

Sobi Investigational Site Prague, Czechia

View all 29 locations

View Trial Details

Recruiting

Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

NCT06905509

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +23 more
Locations: University of California Davis Comprehensive Cancer Center Sacramento, California, United States

View Trial Details

Hemic and Lymphatic Diseases

Hemic and Lymphatic Diseases trial results

Related conditions